Why Alzheimer’s Is No Longer a Black Box: Science, Resilience, and the Path Forward скачать в хорошем качестве

Why Alzheimer’s Is No Longer a Black Box: Science, Resilience, and the Path Forward

Alzheimer’s disease has long been treated as an inevitable part of aging. According to Dr. Jessica Rexach, that assumption is no longer supported by science. In this episode of Research Renaissance, host Deborah Westphal sits down with Dr. Rexach, Assistant Professor at UCLA and 2024 Toffler Scholar, to explore how advances in genetics, biomarkers, and human brain modeling have transformed dementia research. Dr. Rexach explains why Alzheimer’s is no longer a “black box,” how blood-based biomarkers are reshaping clinical trials, and why some brains remain resilient even in the presence of disease pathology. She also addresses the urgent risk facing the field today: loss of funding and scientific momentum at the exact moment breakthroughs are within reach. This conversation is essential viewing for researchers, clinicians, caregivers, policymakers, and anyone interested in the future of brain health. 👉 If you found this discussion helpful, please like the video, subscribe to the channel, and share it with others who care about neuroscience and Alzheimer’s research. 🔔 Subscribe for more conversations at the forefront of brain science.